Anti-VEGF-A Affects the Angiogenic Properties of Tumor-Derived Microparticles

Open Access

Peer-reviewed

Research Article

Michal Munster ,

Contributed equally to this work with: Michal Munster, Ella Fremder

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯
Ella Fremder ,

Contributed equally to this work with: Michal Munster, Ella Fremder

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯
Valeria Miller,

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯
Neta Ben-Tsedek,

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯
Shiri Davidi,

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯
Stefan J. Scherer,

Affiliation Hoffmann La Roche, Basel, Switzerland
⨯
Yuval Shaked

* E-mail: yshaked@tx.technion.ac.il

Affiliation Department of Molecular pharmacology, Rappaport Faculty of Medicine, Technion, Haifa, Israel
⨯

Reader Comments (0)

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Breast tumors
Is the Subject Area "Breast tumors" applicable to this article?

Thanks for your feedback.
Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.